Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
Diseases affecting the eye.
Retinal diseases refer to a diverse group of vision-threatening disorders that affect the retina's structure and function, including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinitis pigmentosa, and macular edema, among others.
Organic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy.
A membrane on the vitreal surface of the retina resulting from the proliferation of one or more of three retinal elements: (1) fibrous astrocytes; (2) fibrocytes; and (3) retinal pigment epithelial cells. Localized epiretinal membranes may occur at the posterior pole of the eye without clinical signs or may cause marked loss of vision as a result of covering, distorting, or detaching the fovea centralis. Epiretinal membranes may cause vascular leakage and secondary retinal edema. In younger individuals some membranes appear to be developmental in origin and occur in otherwise normal eyes. The majority occur in association with retinal holes, ocular concussions, retinal inflammation, or after ocular surgery. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p291)
Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.
Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.
An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina.
The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
A large superfamily of cell surface membrane proteins characterized by their four transmembrane domains. They play a role in a variety of processes such as cellular adhesion and motility. They may be involved in the organization of cell surface MEMBRANE MICRODOMAINS that regulate the activation of LEUKOCYTES.
The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells are macroglia that perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment.
A family of seven-pass transmembrane cell-surface proteins that combines with LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 or LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 to form receptors for WNT PROTEINS. Frizzled receptors often couple with HETEROTRIMERIC G PROTEINS and regulate the WNT SIGNALING PATHWAY.
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
LDL-receptor related protein that combines with FRIZZLED RECEPTORS at the cell surface to form receptors that bind WNT PROTEINS. The protein plays an important role in the WNT SIGNALING PATHWAY in OSTEOBLASTS and during EMBRYONIC DEVELOPMENT.
Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes.
A PDGF receptor that binds specifically to both PDGF-A chains and PDGF-B chains. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.
Hemorrhage into the VITREOUS BODY.
Congenital, often bilateral, retinal abnormality characterized by the arrangement of outer nuclear retinal cells in a palisading or radiating pattern surrounding a central ocular space. This disorder is sometimes hereditary.
A TGF-beta subtype that was originally identified as a GLIOBLASTOMA-derived factor which inhibits the antigen-dependent growth of both helper and CYTOTOXIC T LYMPHOCYTES. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta2 and TGF-beta2 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.
Specialized ophthalmic technique used in the surgical repair and or treatment of disorders that include retinal tears or detachment; MACULAR HOLES; hereditary retinal disease; AIDS-related retinal infections; ocular tumors; MACULAR DEGENERATION; DIABETIC RETINOPATHY; and UVEITIS.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
A family of proteins that share sequence similarity with the low density lipoprotein receptor (RECEPTORS, LDL).
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
'Eye proteins' are structural or functional proteins, such as crystallins, opsins, and collagens, located in various parts of the eye, including the cornea, lens, retina, and aqueous humor, that contribute to maintaining transparency, refractive power, phototransduction, and overall integrity of the visual system.
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.
The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear.
Recording of electric potentials in the retina after stimulation by light.
An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
The blood vessels which supply and drain the RETINA.
Introduction of substances into the body using a needle and syringe.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.
Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.
An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.

Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. (1/199)

PURPOSE: Proliferative vitreoretinopathy (PVR) is a major cause of failure of retinal detachment surgery. It is believed to be a wound-healing process in the retina. Many of the cellular functions are influenced by cytokines and growth factors such as interleukins (ILs). The present study was conducted to investigate the presence of transforming growth factor-beta 2 (TGF-beta2), basic fibroblast growth factor (bFGF), IL-1beta, IL-6, and protein in the vitreous of patients with retinal detachment and to determine the value of these mediators in predicting the future development of PVR. METHODS: A prospective study was conducted in 140 consecutive patients with rhegmatogenous retinal detachment in whom vitrectomy was considered necessary. Vitreous samples were analyzed for the presence of TGF-beta2, bFGF, IL-1beta, IL-6, and protein. Patients were then followed up for 3 months for the development of postoperative PVR. RESULTS: The mean levels of TGF-beta2, bFGF, IL-1beta, and protein in the vitreous were significantly higher (P < 0.05) in patients with preoperative PVR compared with those without. The mean levels of TGF-beta2, bFGF, IL-6, and protein in the vitreous were significantly higher (P < 0.05) in patients who had postoperative PVR compared with those who did not. Multivariate logistic regression analysis showed IL-6 and protein to be significant (P < 0.05), independent, predictive risk factors for the development of PVR. CONCLUSIONS: The various cytokines may play a role in the pathobiology of PVR. High vitreous levels of IL-6 and protein were identified as significant risk factors for PVR. A model was developed to predict the probability of development of postoperative PVR in these patients, and it may be used to indicate intravitreal pharmacologic treatment for those at risk.  (+info)

Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. (2/199)

AIM: To investigate whether high vitreous levels of the soluble intercellular adhesion molecule 1 (sICAM-1) may be related to clinical risk factors of proliferative vitreoretinopathy (PVR) and whether their measurement may serve as an additional risk indicator of this complication in eyes with rhegmatogenous retinal detachment (RRD). METHODS: Levels of sICAM-1 were measured by enzyme linked immunosorbent assays (ELISA) in vitreous from 36 eyes with RRD clinically considered to be at high risk of developing PVR (large retinal breaks, vitreous haemorrhage, long standing RRD, and previous vitreoretinal surgery). Levels of sICAM-1 in this group were compared with those in vitreous from 31 eyes with RRD without clinical risk factors for PVR, 32 eyes with established PVR and 10 eyes with macular holes. RESULTS: Vitreous from eyes with RRD at high risk of developing PVR contained significantly higher levels of sICAM-1 (range 6.1-97.7 ng/ml; Mann-Whitney test, p=0.0002) than those from eyes with RRD at low risk of developing this complication (range 4.8-17.7 ng/ml). Vitreous sICAM-1 levels in eyes with RRD at high risk of developing PVR were significantly lower than in eyes with established PVR (p=0.037), but higher than in eyes with macular holes (p <0.0001). Levels of sICAM-1 >/=15 ng/ml (3 x median of the levels present in control eyes) provide a useful cut off point for a highly specific test (96.7%) with high positive (91.6%) and negative (96.7%) predictive values, despite a relatively low sensitivity (30. 5%). CONCLUSIONS: The present findings suggest that laboratory measurement of sICAM-1 levels in vitreous from eyes with RRD may constitute an additional factor for identifying patients at high risk of PVR. Hence, determination of sICAM-1 levels may aid in the monitoring of patients likely to develop this complication and in the identification of patients who may benefit from adjuvant anti-inflammatory therapy.  (+info)

Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. (3/199)

PURPOSE: To improve our understanding of how retinal pigment epithelial (RPE) cells behave in vivo and to establish similarities with dedifferentiation and adaptive events observed in RPE cells cultured under simulated intraocular pathologic conditions. At the same time, to examine the origin of epithelioid-shaped and fibroblast/fusiform-shaped cells in epiretinal membranes (ERM) from proliferative vitreoretinopathy (PVR). METHODS: Cells of ERM were studied by electron-immunocytochemical techniques, using simple, double, and triple immunostaining for cytokeratins (CK), vimentin (Vim), and glial fibrillary acidic protein (GFAP). Ultrastructural morphology analysis was also carried out. Adult human RPE cells were obtained and cultured with normal and pathologic vitreous from proliferative vitreoretinal disorders, subretinal fluid aspirates from retinal detachment, and normal human serum. Their cytoskeleton was fractionated at 7 (early cultures) and 24 (late cultures) days of culture, electrophoresed, immunoblotted for intermediate filament proteins, and quantified by densitometric analysis for each condition. Changes in phenotype characteristics were also evaluated. RESULTS: Epithelioid-shaped and fibroblast/fusiform-shaped cells, resembling RPE cells, expressed CK-Vim-GFAP simultaneously as intermediate filament proteins in their cytoskeleton. RPE cells in culture also expressed CK-Vim-GFAP and changed from an epithelial shape to a migratory fibroblast/fusiform-shaped phenotype in the presence of subretinal fluid aspirates and pathologic vitreous from proliferative intraocular disorders. In simulated cultures of proliferative intraocular disorders, cells decreased or retained their CK7, CK8, and CK18, retained Vim, and increased CK19 and GFAP, while their mesenchymal morphology became clearer over time. CONCLUSIONS: Studies of intermediate filament proteins in vivo suggest that dedifferentiation occurs in RPE cells in ERM. Dedifferentiated RPE cells may be responsible for epithelioid-like and fibroblast/fusiform-like cells. Furthermore, changes in intermediate filament protein levels were observed in RPE cells in simulated cultures of proliferative intraocular disorders. These changes were linked to cells acquiring a mesenchymal migratory, phenotype. Results indicate that the dedifferentiation of RPE cells occurs both in vivo and in vitro and that it can be explained as an epithelial-mesenchymal transition.  (+info)

Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. (4/199)

PURPOSE: The action of growth factors is thought to make a substantial contribution to the events leading to proliferative vitreoretinopathy (PVR). In this study, the importance of platelet-derived growth factor (PDGF) was tested in a rabbit model of PVR. METHODS: The approach was to compare the extent of PVR induced by cells that do or do not express the receptors for PDGF and therefore differ in their ability to respond to PDGF. RESULTS: Mouse embryo fibroblasts derived from PDGF receptor knock-out embryos that do not express either of the two PDGF receptors induced PVR poorly when injected into the eyes of rabbits that had previously undergone gas vitrectomy. Re-expression of the PDGF beta receptor in these cells did not improve the ability of the cells to cause PVR. In contrast, injection of cells expressing the PDGF alpha receptor resulted in stage 3 or higher PVR in 8 of 10 animals. CONCLUSIONS: These findings show that PDGF makes an important contribution to the development of PVR in this animal model. Furthermore, there is a marked difference between the two receptors for PDGF, and it is the PDGF alpha receptor that is capable of driving events that lead to PVR.  (+info)

Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. (5/199)

AIMS: To determine whether the infiltrating cells in the vitreous and subretinal fluid of patients with proliferative vitreoretinopathy (PVR) express messenger RNA for various cytokines found in this condition. METHODS: The presence of mRNA coding for HPRT, IL-6, IL-1beta, IL-8, and TNFalpha was investigated in 20 vitreous and subretinal fluid (SRF) samples from patients with PVR by reverse transcriptase polymerase chain reaction (RT-PCR). 16 samples from patients with retinal detachment and macular holes were used as controls. RESULTS: HPRT was detected in all samples of PVR and in 11 (69%) control cases. Patients with PVR demonstrated mRNA for the cytokines tested more often than controls. The difference was statistically significant. CONCLUSION: The presence of mRNA encoding for IL-6, IL-1beta, IL-8, and TNFalpha is significantly detected by RT-PCR in vitreous and SRF samples of patients with PVR, indicating local production of these cytokines by vitreous and SRF cells.  (+info)

Human Muller glial cells: altered potassium channel activity in proliferative vitreoretinopathy. (6/199)

PURPOSE: To determine differences of K+ channel activity between Muller glial cells obtained from retinas of healthy human donors and of patients with retinal detachment and proliferative vitreoretinopathy. METHODS: Muller cells were enzymatically isolated from retinas of healthy donors and from excised retinal pieces of patients. The whole-cell and the cell-attached configurations of the patch-clamp technique were used to characterize the current densities of different K+ channel types and the activity of single Ca2+ -activated K+ channels of big conductance (BK). RESULTS: Cells from patients displayed a less negative mean membrane potential (-52.8 mV) than cells from healthy donors (-80.6 mV). However, the membrane potentials in cells from patients scattered largely between -6 and -99 mV. The inwardly rectifying K+ permeability in cells from patients was strongly reduced (0.3 pA/pF) when compared with cells from healthy donors (6.0 pA/pF). At the resting membrane potential, single BK channels displayed a higher mean activity (open probability, Po, and channel current amplitude) in cells from patients (Po, 0.30) than in cells from healthy donors (Po: 0.03). The variations of BK current amplitudes were correlated with the variations of the membrane potential. CONCLUSIONS: The dominant expression of inwardly rectifying channels in cells from healthy donors is thought to support important glial cell functions such as the spatial buffering of extracellular K+. The downregulation of these channels and the less negative mean membrane potential in cells from patients should impair spatial buffering currents and neurotransmitter clearance. The increased activity of BK channels may support the proliferative activity of gliotic cells via feedback regulation of Ca2+ entry and membrane potential.  (+info)

Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression. (7/199)

We tested the hypothesis that Src family kinases (SFK) contribute to c-Cbl-mediated degradation of the platelet-derived growth factor (PDGF) alpha receptor (alphaPDGFR). Using either a receptor mutant that does not engage SFKs (F72/74), or cells that that lack SFKs, we found that SFKs contributed to degradation of the alphaPDGFR. Overexpression of c-Cbl also reduced the receptor half-life, but only if the receptor was able to engage SFKs. In cultured cells, prolonging the half-life of the receptor correlated with enhanced signaling and more efficient S phase entry, whereas accelerating receptor degradation had the opposite effect. Consistent with these tissue culture findings, there was a statistically significant increase in the onset of a proliferative retinal disease when animals were injected with cells expressing the F72/74 receptor, as compared with cells expressing the WT receptor. Our findings suggest that SFKs cooperate with c-Cbl to negatively regulate the alphaPDGFR, and that the SFK/c-Cbl suppression of alphaPDGFR output is relevant to the onset and progression of a proliferative disease.  (+info)

IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. (8/199)

PURPOSE: Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell-mediated contraction of the retina. METHODS: Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-beta1, TGF-beta2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-beta2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area. RESULTS: RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-beta2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-beta2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-beta2 on RPE-mediated contraction of the retina (P < 0.01). CONCLUSIONS: These findings confirm a role for both PDGF and TGF-beta2 in RPE cell-mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-beta2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.  (+info)

Proliferative vitreoretinopathy (PVR) is a sight-threatening complication that can occur after open-globe eye injuries or retinal reattachment surgery. It is characterized by the abnormal growth and contraction of fibrous tissue on the surface of the retina and/or inside the vitreous cavity, which can cause distortion or detachment of the retina. This process can lead to visual impairment or even blindness if left untreated.

The term "proliferative" refers to the abnormal growth of cells (specifically, fibrous and inflammatory cells) on the retinal surface and within the vitreous cavity. These cells form membranes that can contract and cause traction on the retina, leading to distortion or detachment.

PVR is classified into three stages (A, B, and C) based on the extent of fibrous tissue formation and retinal changes. Stage A is characterized by the presence of cellular proliferation without any visible membranes or retinal changes. In stage B, fibrous membranes are present, but there is no retinal detachment. Finally, stage C involves the development of tractional retinal detachment due to the contraction of fibrous membranes.

Treatment for PVR typically involves additional surgical intervention to remove or release the fibrous tissue and reattach the retina. The prognosis for visual recovery depends on the severity and extent of the PVR, as well as the timing and success of treatment.

Retinal detachment is a serious eye condition that occurs when the retina, a thin layer of tissue at the back of the eye responsible for processing light and sending visual signals to the brain, pulls away from its normal position. This can lead to significant vision loss or even blindness if not promptly treated. Retinal detachment can be caused by various factors such as aging, trauma, eye disease, or an inflammatory condition. Symptoms of retinal detachment may include sudden flashes of light, floaters, a shadow in the peripheral vision, or a curtain-like covering over part of the visual field. Immediate medical attention is necessary to prevent further damage and preserve vision.

The vitreous body, also known simply as the vitreous, is the clear, gel-like substance that fills the space between the lens and the retina in the eye. It is composed mainly of water, but also contains collagen fibers, hyaluronic acid, and other proteins. The vitreous helps to maintain the shape of the eye and provides a transparent medium for light to pass through to reach the retina. With age, the vitreous can become more liquefied and may eventually separate from the retina, leading to symptoms such as floaters or flashes of light.

Eye diseases are a range of conditions that affect the eye or visual system, causing damage to vision and, in some cases, leading to blindness. These diseases can be categorized into various types, including:

1. Refractive errors: These include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, which affect the way light is focused on the retina and can usually be corrected with glasses or contact lenses.
2. Cataracts: A clouding of the lens inside the eye that leads to blurry vision, glare, and decreased contrast sensitivity. Cataract surgery is the most common treatment for this condition.
3. Glaucoma: A group of diseases characterized by increased pressure in the eye, leading to damage to the optic nerve and potential blindness if left untreated. Treatment includes medications, laser therapy, or surgery.
4. Age-related macular degeneration (AMD): A progressive condition that affects the central part of the retina called the macula, causing blurry vision and, in advanced stages, loss of central vision. Treatment may include anti-VEGF injections, laser therapy, or nutritional supplements.
5. Diabetic retinopathy: A complication of diabetes that affects the blood vessels in the retina, leading to bleeding, leakage, and potential blindness if left untreated. Treatment includes laser therapy, anti-VEGF injections, or surgery.
6. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly with surgery.
7. Amblyopia (lazy eye): A condition where one eye does not develop normal vision, often due to a misalignment or refractive error in childhood. Treatment includes correcting the underlying problem and encouraging the use of the weaker eye through patching or other methods.
8. Strabismus (crossed eyes): A misalignment of the eyes that can lead to amblyopia if not treated promptly with surgery, glasses, or other methods.
9. Corneal diseases: Conditions that affect the transparent outer layer of the eye, such as keratoconus, Fuchs' dystrophy, and infectious keratitis, which can lead to vision loss if not treated promptly.
10. Uveitis: Inflammation of the middle layer of the eye, which can cause vision loss if not treated promptly with anti-inflammatory medications or surgery.

Retinal diseases refer to a group of conditions that affect the retina, which is the light-sensitive tissue located at the back of the eye. The retina is responsible for converting light into electrical signals that are sent to the brain and interpreted as visual images. Retinal diseases can cause vision loss or even blindness, depending on their severity and location in the retina.

Some common retinal diseases include:

1. Age-related macular degeneration (AMD): A progressive disease that affects the central part of the retina called the macula, causing blurred or distorted vision.
2. Diabetic retinopathy: A complication of diabetes that can damage the blood vessels in the retina, leading to vision loss.
3. Retinal detachment: A serious condition where the retina becomes separated from its underlying tissue, requiring immediate medical attention.
4. Macular edema: Swelling or thickening of the macula due to fluid accumulation, which can cause blurred vision.
5. Retinitis pigmentosa: A group of inherited eye disorders that affect the retina's ability to respond to light, causing progressive vision loss.
6. Macular hole: A small break in the macula that can cause distorted or blurry vision.
7. Retinal vein occlusion: Blockage of the retinal veins that can lead to bleeding, swelling, and potential vision loss.

Treatment for retinal diseases varies depending on the specific condition and its severity. Some treatments include medication, laser therapy, surgery, or a combination of these options. Regular eye exams are essential for early detection and treatment of retinal diseases.

Silicone oils are synthetic, polymerized forms of siloxane, which is a type of silicon-based compound. These oils are known for their stability, durability, and resistance to heat, chemicals, and aging. In the medical field, silicone oils are often used in various medical devices and procedures, such as:

1. Intraocular lenses: Silicone oils can be used as a temporary replacement for the vitreous humor (the gel-like substance that fills the eye) during vitreoretinal surgery, particularly when there is a retinal detachment or other serious eye conditions. The oil helps to reattach the retina and maintain its position until a permanent solution can be found.

2. Breast implants: Silicone oils are used as a filling material for breast implants due to their ability to mimic the feel of natural breast tissue. However, the use of silicone breast implants has been controversial due to concerns about potential health risks, including immune system disorders and cancer.

3. Drug delivery systems: Silicone oils can be used as a component in drug-eluting devices, which are designed to deliver medication slowly and consistently over an extended period. These devices can be used in various medical applications, such as wound healing or the treatment of chronic pain.

4. Medical adhesives: Silicone oils can be incorporated into medical adhesives to improve their flexibility, biocompatibility, and resistance to moisture and heat. These adhesives are often used in the manufacturing of medical devices and for securing bandages or dressings to the skin.

It is important to note that while silicone oils have many medical applications, they can also pose potential risks, such as migration, inflammation, or other complications. Therefore, their use should be carefully considered and monitored by healthcare professionals.

An epiretinal membrane, also known as a macular pucker or cellophane maculopathy, is a thin and transparent layer of tissue that forms over the macula (the central part of the retina responsible for sharp, detailed vision) in the eye. This membrane can contract and wrinkle the macula, distorting central vision.

Epiretinal membranes are typically caused by the migration and proliferation of glial cells or other cell types onto the surface of the retina following retinal injury, inflammation, or aging. In some cases, they may be associated with other eye conditions such as diabetic retinopathy, retinal vein occlusion, or age-related macular degeneration.

Mild epiretinal membranes may not require treatment, but if the distortion of vision is significant, a vitrectomy surgery may be recommended to remove the membrane and improve visual acuity.

Hereditary eye diseases refer to conditions that affect the eyes and are passed down from parents to their offspring through genetics. These diseases are caused by mutations or changes in an individual's DNA that are inherited from their parents. The mutations can occur in any of the genes associated with eye development, function, or health.

There are many different types of hereditary eye diseases, some of which include:

1. Retinitis Pigmentosa - a group of rare, genetic disorders that involve a breakdown and loss of cells in the retina.
2. Macular Degeneration - a progressive disease that damages the central portion of the retina, impairing vision.
3. Glaucoma - a group of eye conditions that damage the optic nerve, often caused by an increase in pressure inside the eye.
4. Cataracts - clouding of the lens inside the eye, which can lead to blurry vision and blindness.
5. Keratoconus - a progressive eye disease that causes the cornea to thin and bulge outward into a cone shape.
6. Color Blindness - a condition where an individual has difficulty distinguishing between certain colors.
7. Optic Neuropathy - damage to the optic nerve, which can result in vision loss.

The symptoms and severity of hereditary eye diseases can vary widely depending on the specific condition and the individual's genetic makeup. Some conditions may be present at birth or develop in early childhood, while others may not appear until later in life. Treatment options for these conditions may include medication, surgery, or lifestyle changes, and are often most effective when started early.

A vitrectomy is a surgical procedure that involves the removal of some or all of the vitreous humor, which is the clear gel-like substance filling the center of the eye. This surgery is often performed to treat various retinal disorders such as diabetic retinopathy, retinal detachment, macular hole, and vitreous hemorrhage.

During a vitrectomy, the ophthalmologist makes small incisions in the sclera (the white part of the eye) to access the vitreous cavity. The surgeon then uses specialized instruments to remove the cloudy or damaged vitreous and may also repair any damage to the retina or surrounding tissues. Afterward, a clear saline solution is injected into the eye to maintain its shape and help facilitate healing.

In some cases, a gas bubble or silicone oil may be placed in the eye after the vitrectomy to help hold the retina in place while it heals. These substances will gradually be absorbed or removed during follow-up appointments. The body naturally produces a new, clear vitreous to replace the removed material over time.

Vitrectomy is typically performed under local anesthesia and may require hospitalization or outpatient care depending on the individual case. Potential risks and complications include infection, bleeding, cataract formation, retinal detachment, and increased eye pressure. However, with proper care and follow-up, most patients experience improved vision after a successful vitrectomy procedure.

Scleral buckling is a surgical procedure used to treat retinal detachment, a serious eye condition that can cause vision loss. In this procedure, the sclera (the white outer coat of the eye) is "buckled" or indented with a piece of silicone rubber or sponge material. This brings the detached retina into contact with the wall of the eye, allowing the retina to reattach and heal. The buckle is usually left in place permanently. Scleral buckling has been a standard treatment for retinal detachment for many years and is often combined with vitrectomy or cryotherapy to improve outcomes.

The pigment epithelium of the eye, also known as the retinal pigment epithelium (RPE), is a layer of cells located between the photoreceptor cells of the retina and the choroid, which is the vascular layer of the eye. The RPE plays a crucial role in maintaining the health and function of the photoreceptors by providing them with nutrients, removing waste products, and helping to regulate the light that enters the eye.

The RPE cells contain pigment granules that absorb excess light, preventing it from scattering within the eye and improving visual acuity. They also help to create a barrier between the retina and the choroid, which is important for maintaining the proper functioning of the photoreceptors. Additionally, the RPE plays a role in the regeneration of visual pigments in the photoreceptor cells, allowing us to see in different light conditions.

Damage to the RPE can lead to various eye diseases and conditions, including age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults.

Exudates and transudates are two types of bodily fluids that can accumulate in various body cavities or tissues as a result of injury, inflammation, or other medical conditions. Here are the medical definitions:

1. Exudates: These are fluids that accumulate due to an active inflammatory process. Exudates contain high levels of protein, white blood cells (such as neutrophils and macrophages), and sometimes other cells like red blood cells or cellular debris. They can be yellow, green, or brown in color and may have a foul odor due to the presence of dead cells and bacteria. Exudates are often seen in conditions such as abscesses, pneumonia, pleurisy, or wound infections.

Examples of exudative fluids include pus, purulent discharge, or inflammatory effusions.

2. Transudates: These are fluids that accumulate due to increased hydrostatic pressure or decreased oncotic pressure within the blood vessels. Transudates contain low levels of protein and cells compared to exudates. They are typically clear and pale yellow in color, with no odor. Transudates can be found in conditions such as congestive heart failure, liver cirrhosis, or nephrotic syndrome.

Examples of transudative fluids include ascites, pleural effusions, or pericardial effusions.

It is essential to differentiate between exudates and transudates because their underlying causes and treatment approaches may differ significantly. Medical professionals often use various tests, such as fluid analysis, to determine whether a fluid sample is an exudate or transudate.

Tetraspanins are a family of membrane proteins that are characterized by the presence of four transmembrane domains. They are widely expressed in various tissues and cells, where they play important roles in regulating cell development, activation, motility, and fusion. Tetraspanins can interact with other membrane proteins, such as integrins, receptors, and enzymes, to form complexes that function in signal transduction, trafficking, and adhesion. They also participate in the regulation of various cellular processes, including cell proliferation, differentiation, survival, and apoptosis. Some tetraspanins have been implicated in the pathogenesis of various diseases, such as cancer, autoimmune disorders, and viral infections.

The retinal pigment epithelium (RPE) is a single layer of cells located between the photoreceptor cells of the retina and the choroid, which is a part of the eye containing blood vessels. The RPE plays a crucial role in maintaining the health and function of the photoreceptors by providing them with nutrients, removing waste products, and helping to regulate the light-sensitive visual pigments within the photoreceptors.

The RPE cells contain pigment granules that absorb excess light to prevent scattering within the eye and improve visual acuity. They also help to form the blood-retina barrier, which restricts the movement of certain molecules between the retina and the choroid, providing an important protective function for the retina.

Damage to the RPE can lead to a variety of eye conditions, including age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults.

Frizzled receptors are a type of cell surface receptor that are involved in the Wnt signaling pathway. They are named after the Drosophila melanogaster (fruit fly) mutant phenotype "frizzy" because of their role in regulating cell fate and patterning during development.

Frizzled receptors are composed of a seven-pass transmembrane domain, an extracellular cysteine-rich domain, and an intracellular tail. They bind to Wnt ligands, which are secreted proteins that play important roles in cell-cell communication during development and tissue homeostasis.

There are ten different Frizzled receptors identified in humans (FZD1-10) that can activate multiple signaling pathways, including the canonical Wnt/β-catenin pathway, noncanonical planar cell polarity pathway, and the Wnt/Ca2+ pathway. Dysregulation of Frizzled receptors has been implicated in various diseases, such as cancer, neurodevelopmental disorders, and metabolic disorders.

"Fundus Oculi" is a medical term that refers to the back part of the interior of the eye, including the optic disc, macula, fovea, retinal vasculature, and peripheral retina. It is the area where light is focused and then transmitted to the brain via the optic nerve, forming visual images. Examinations of the fundus oculi are crucial for detecting various eye conditions such as diabetic retinopathy, macular degeneration, glaucoma, and other retinal diseases. The examination is typically performed using an ophthalmoscope or a specialized camera called a retinal camera.

The retina is the innermost, light-sensitive layer of tissue in the eye of many vertebrates and some cephalopods. It receives light that has been focused by the cornea and lens, converts it into neural signals, and sends these to the brain via the optic nerve. The retina contains several types of photoreceptor cells including rods (which handle vision in low light) and cones (which are active in bright light and are capable of color vision).

In medical terms, any pathological changes or diseases affecting the retinal structure and function can lead to visual impairment or blindness. Examples include age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinitis pigmentosa among others.

Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5) is a gene that encodes a single transmembrane protein, which belongs to the low-density lipoprotein receptor family. This protein plays crucial roles in various biological processes such as bone formation, vascular biology, and cancer progression. It functions as a co-receptor for Wnt signaling pathways that regulate gene expression involved in cell proliferation, differentiation, and migration.

In the context of lipid metabolism, LRP5 has been shown to modulate lipoprotein particle uptake and cholesterol homeostasis through its interaction with LDL receptors. Mutations in the LRP5 gene have been associated with several diseases, including osteoporosis, familial exudative vitreoretinopathy, and adiposity-associated disorders.

In summary, Low-Density Lipoprotein Receptor-Related Protein 5 is a multifunctional receptor involved in various physiological processes, including bone formation, lipid metabolism, and cell signaling.

A retinal perforation is a full-thickness break or hole in the retina, which is the light-sensitive tissue that lines the inner surface of the eye. This condition can lead to a serious complication called retinal detachment, where the retina separates from the underlying tissue, potentially resulting in vision loss if not promptly treated. Retinal perforations may be caused by trauma, certain eye conditions, or invasive eye procedures. Immediate medical attention is required for retinal perforations to prevent further damage and preserve vision.

The platelet-derived growth factor receptor alpha (PDGFR-α) is a type of cell surface receptor that binds to specific proteins called platelet-derived growth factors (PDGFs). PDGFR-α is a transmembrane tyrosine kinase receptor, which means it has an intracellular portion containing tyrosine kinase enzymatic activity.

When PDGFs bind to PDGFR-α, they induce receptor dimerization and activation of the tyrosine kinase domain, leading to autophosphorylation of specific tyrosine residues on the receptor. This triggers a signaling cascade that promotes cell growth, proliferation, survival, and migration. PDGFR-α is primarily expressed in cells of mesenchymal origin, such as fibroblasts, smooth muscle cells, and glial cells.

PDGFR-α plays crucial roles during embryonic development, wound healing, and tissue repair. However, aberrant activation or mutations in PDGFR-α have been implicated in various pathological conditions, including cancer, atherosclerosis, and fibrotic disorders. Therefore, PDGFR-α is an important target for therapeutic interventions in these diseases.

A Vitreous Hemorrhage is a medical condition where there is bleeding into the vitreous cavity of the eye. The vitreous cavity is the space in the eye that is filled with a clear, gel-like substance called the vitreous humor. This substance helps to maintain the shape of the eye and transmit light to the retina.

When a vitreous hemorrhage occurs, blood cells from the bleeding mix with the vitreous humor, causing it to become cloudy or hazy. As a result, vision can become significantly impaired, ranging from mildly blurry to complete loss of vision depending on the severity of the bleed.

Vitreous hemorrhages can occur due to various reasons such as trauma, retinal tears or detachments, diabetic retinopathy, age-related macular degeneration, and other eye conditions that affect the blood vessels in the eye. Treatment for vitreous hemorrhage depends on the underlying cause and may include observation, laser surgery, or vitrectomy (a surgical procedure to remove the vitreous humor and stop the bleeding).

Retinal dysplasia is a developmental abnormality of the retina, which is the light-sensitive tissue located at the back of the eye. This condition is characterized by the presence of folds or rosettes (round clusters) in the retinal structure, resulting from improper or disorganized growth of the retinal cells during fetal development.

Retinal dysplasia can be classified into two types:

1. Focal or localized retinal dysplasia: This type is limited to a small area of the retina and usually does not significantly affect vision. It may present as mild folds or rosettes in the retinal structure.
2. Generalized or severe retinal dysplasia: This type involves widespread disorganization of the retinal layers, leading to more significant visual impairment. In extreme cases, it can result in complete detachment of the retina from the underlying tissue, causing blindness.

Retinal dysplasia can be an isolated finding or associated with various genetic disorders, infections, or environmental factors during pregnancy. Depending on the severity and underlying cause, management may include monitoring for visual development, corrective lenses, or treatment of associated conditions.

Transforming Growth Factor beta2 (TGF-β2) is a type of cytokine, specifically a growth factor, that plays a role in cell growth, division, and apoptosis (programmed cell death). It belongs to the TGF-β family of proteins. TGF-β2 is involved in various biological processes such as embryonic development, tissue homeostasis, wound healing, and immune regulation. In particular, it has been implicated in the regulation of extracellular matrix production and fibrosis, making it an important factor in diseases that involve excessive scarring or fibrotic changes, such as glaucoma, Marfan syndrome, and systemic sclerosis.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Eye injuries refer to any damage or trauma caused to the eye or its surrounding structures. These injuries can vary in severity and may include:

1. Corneal abrasions: A scratch or scrape on the clear surface of the eye (cornea).
2. Chemical burns: Occurs when chemicals come into contact with the eye, causing damage to the cornea and other structures.
3. Eyelid lacerations: Cuts or tears to the eyelid.
4. Subconjunctival hemorrhage: Bleeding under the conjunctiva, the clear membrane that covers the white part of the eye.
5. Hyphema: Accumulation of blood in the anterior chamber of the eye, which is the space between the cornea and iris.
6. Orbital fractures: Breaks in the bones surrounding the eye.
7. Retinal detachment: Separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly.
8. Traumatic uveitis: Inflammation of the uvea, the middle layer of the eye, caused by trauma.
9. Optic nerve damage: Damage to the optic nerve, which transmits visual information from the eye to the brain.

Eye injuries can result from a variety of causes, including accidents, sports-related injuries, violence, and chemical exposure. It is important to seek medical attention promptly for any suspected eye injury to prevent further damage and potential vision loss.

Vitreoretinal surgery is a specialized ophthalmic surgical procedure that deals with the treatment of various conditions related to the vitreous humor (the clear gel-like substance filling the space between the lens and the retina) and the retina (the light-sensitive tissue lining the inner surface of the eye). This type of surgery is typically performed by a vitreoretinal surgeon, who has additional fellowship training in this subspecialty.

The main indications for vitreoretinal surgery include:

1. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly.
2. Macular holes: Small breaks or tears in the center of the macula (the part of the retina responsible for sharp, central vision).
3. Epiretinal membranes: Thin layers of scar tissue that form on the surface of the retina and can distort vision.
4. Vitreous hemorrhage: Bleeding into the vitreous humor, often caused by diabetic retinopathy or other retinal vascular diseases.
5. Intraocular foreign bodies: The removal of objects that have accidentally entered the eye.
6. Advanced cases of age-related macular degeneration (AMD) and other retinal disorders.

During vitreoretinal surgery, the surgeon makes small incisions in the eye to access the vitreous cavity and the retina. The vitreous humor is removed using specialized instruments, such as a vitrectomy cutter or forceps. Then, the surgeon can perform various procedures to address the underlying condition, like repairing retinal tears, removing scar tissue, or applying a gas or oil bubble to help reattach the retina. Finally, the eye is often filled with a saline solution, air, or a special type of gas or oil to maintain the proper shape and pressure inside the eye.

Vitreoretinal surgery requires advanced technical skills and expertise, as well as a thorough understanding of the anatomy and pathophysiology of the vitreous and retina. The primary goal of this procedure is to preserve or improve vision by addressing the underlying condition and preventing further damage to the delicate structures of the eye.

Visual acuity is a measure of the sharpness or clarity of vision. It is usually tested by reading an eye chart from a specific distance, such as 20 feet (6 meters). The standard eye chart used for this purpose is called the Snellen chart, which contains rows of letters that decrease in size as you read down the chart.

Visual acuity is typically expressed as a fraction, with the numerator representing the testing distance and the denominator indicating the smallest line of type that can be read clearly. For example, if a person can read the line on the eye chart that corresponds to a visual acuity of 20/20, it means they have normal vision at 20 feet. If their visual acuity is 20/40, it means they must be as close as 20 feet to see what someone with normal vision can see at 40 feet.

It's important to note that visual acuity is just one aspect of overall vision and does not necessarily reflect other important factors such as peripheral vision, depth perception, color vision, or contrast sensitivity.

I'm sorry for any confusion, but "Fluorocarbons" are not typically associated with medical definitions. Fluorocarbons are chemical compounds that contain carbon atoms bonded to fluorine atoms. They are often used in a variety of applications including refrigerants, fire extinguishing agents, and in the manufacturing of Teflon and other non-stick coatings.

If you have any medical terms or concepts you'd like me to define or explain, please let me know!

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

LDL-Receptor Related Proteins (LRP) are a family of single transmembrane domain receptors that play important roles in various cellular processes, including endocytosis, intracellular signaling, and protein degradation. They are named after their structural and functional similarities to the low-density lipoprotein (LDL) receptor.

The LDL-Receptor Related Proteins consist of several members, including LRP1, LRP2 (also known as Megalin), LRP3, LRP4, LRP5, and LRP6. These proteins are widely expressed in various tissues, such as the brain, liver, kidney, and muscle.

LRP1 is a large receptor that is involved in the clearance of several ligands, including LDL, apolipoprotein E (apoE), and α2-macroglobulin. It also plays a role in intracellular signaling pathways related to cell survival, differentiation, and migration.

LRP2 is primarily expressed in the kidney and the brain, where it functions as a scavenger receptor that mediates the endocytosis of various ligands, including lipoproteins, vitamin-binding proteins, and enzymes.

LRP3 is involved in the clearance of apoE-containing lipoproteins and has been implicated in the regulation of cholesterol metabolism.

LRP4 is a critical regulator of neuromuscular junction formation and function, and it interacts with several ligands, including agrin and LDL.

LRP5 and LRP6 are involved in the Wnt signaling pathway, which plays important roles in embryonic development, tissue homeostasis, and cancer. They act as co-receptors for Wnt proteins and modulate intracellular signaling pathways that regulate gene expression and cell behavior.

Overall, LDL-Receptor Related Proteins play diverse and critical roles in various physiological processes, and their dysfunction has been implicated in several diseases, including neurodegenerative disorders, cardiovascular disease, and cancer.

Diabetic retinopathy is a diabetes complication that affects the eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).

At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition usually affects both eyes.

There are two main stages of diabetic retinopathy:

1. Early diabetic retinopathy. This is when the blood vessels in the eye start to leak fluid or bleed. You might not notice any changes in your vision at this stage, but it's still important to get treatment because it can prevent the condition from getting worse.
2. Advanced diabetic retinopathy. This is when new, abnormal blood vessels grow on the surface of the retina. These vessels can leak fluid and cause severe vision problems, including blindness.

Diabetic retinopathy can be treated with laser surgery, injections of medication into the eye, or a vitrectomy (a surgical procedure to remove the gel-like substance that fills the center of the eye). It's important to get regular eye exams to detect diabetic retinopathy early and get treatment before it causes serious vision problems.

Eye proteins, also known as ocular proteins, are specific proteins that are found within the eye and play crucial roles in maintaining proper eye function and health. These proteins can be found in various parts of the eye, including the cornea, iris, lens, retina, and other structures. They perform a wide range of functions, such as:

1. Structural support: Proteins like collagen and elastin provide strength and flexibility to the eye's tissues, enabling them to maintain their shape and withstand mechanical stress.
2. Light absorption and transmission: Proteins like opsins and crystallins are involved in capturing and transmitting light signals within the eye, which is essential for vision.
3. Protection against damage: Some eye proteins, such as antioxidant enzymes and heat shock proteins, help protect the eye from oxidative stress, UV radiation, and other environmental factors that can cause damage.
4. Regulation of eye growth and development: Various growth factors and signaling molecules, which are protein-based, contribute to the proper growth, differentiation, and maintenance of eye tissues during embryonic development and throughout adulthood.
5. Immune defense: Proteins involved in the immune response, such as complement components and immunoglobulins, help protect the eye from infection and inflammation.
6. Maintenance of transparency: Crystallin proteins in the lens maintain its transparency, allowing light to pass through unobstructed for clear vision.
7. Neuroprotection: Certain eye proteins, like brain-derived neurotrophic factor (BDNF), support the survival and function of neurons within the retina, helping to preserve vision.

Dysfunction or damage to these eye proteins can contribute to various eye disorders and diseases, such as cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and others.

The Fluorescent Antibody Technique (FAT), Indirect is a type of immunofluorescence assay used to detect the presence of specific antigens in a sample. In this method, the sample is first incubated with a primary antibody that binds to the target antigen. After washing to remove unbound primary antibodies, a secondary fluorescently labeled antibody is added, which recognizes and binds to the primary antibody. This indirect labeling approach allows for amplification of the signal, making it more sensitive than direct methods. The sample is then examined under a fluorescence microscope to visualize the location and amount of antigen based on the emitted light from the fluorescent secondary antibody. It's commonly used in diagnostic laboratories for detection of various bacteria, viruses, and other antigens in clinical specimens.

Dominant genes refer to the alleles (versions of a gene) that are fully expressed in an individual's phenotype, even if only one copy of the gene is present. In dominant inheritance patterns, an individual needs only to receive one dominant allele from either parent to express the associated trait. This is in contrast to recessive genes, where both copies of the gene must be the recessive allele for the trait to be expressed. Dominant genes are represented by uppercase letters (e.g., 'A') and recessive genes by lowercase letters (e.g., 'a'). If an individual inherits one dominant allele (A) from either parent, they will express the dominant trait (A).

Neuroglia, also known as glial cells or simply glia, are non-neuronal cells that provide support and protection for neurons in the nervous system. They maintain homeostasis, form myelin sheaths around nerve fibers, and provide structural support. They also play a role in the immune response of the central nervous system. Some types of neuroglia include astrocytes, oligodendrocytes, microglia, and ependymal cells.

Electroretinography (ERG) is a medical test used to evaluate the functioning of the retina, which is the light-sensitive tissue located at the back of the eye. The test measures the electrical responses of the retina to light stimulation.

During the procedure, a special contact lens or electrode is placed on the surface of the eye to record the electrical activity generated by the retina's light-sensitive cells (rods and cones) and other cells in the retina. The test typically involves presenting different levels of flashes of light to the eye while the electrical responses are recorded.

The resulting ERG waveform provides information about the overall health and function of the retina, including the condition of the photoreceptors, the integrity of the inner retinal layers, and the health of the retinal ganglion cells. This test is often used to diagnose and monitor various retinal disorders, such as retinitis pigmentosa, macular degeneration, and diabetic retinopathy.

Glial Fibrillary Acidic Protein (GFAP) is a type of intermediate filament protein that is primarily found in astrocytes, which are a type of star-shaped glial cells in the central nervous system (CNS). These proteins play an essential role in maintaining the structural integrity and stability of astrocytes. They also participate in various cellular processes such as responding to injury, providing support to neurons, and regulating the extracellular environment.

GFAP is often used as a marker for astrocytic activation or reactivity, which can occur in response to CNS injuries, neuroinflammation, or neurodegenerative diseases. Elevated GFAP levels in cerebrospinal fluid (CSF) or blood can indicate astrocyte damage or dysfunction and are associated with several neurological conditions, including traumatic brain injury, stroke, multiple sclerosis, Alzheimer's disease, and Alexander's disease.

Human chromosome pair 11 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each member of the pair is a single chromosome, and together they contain the genetic material that is inherited from both parents. They are located on the eleventh position in the standard karyotype, which is a visual representation of the 23 pairs of human chromosomes.

Chromosome 11 is one of the largest human chromosomes and contains an estimated 135 million base pairs. It contains approximately 1,400 genes that provide instructions for making proteins, as well as many non-coding RNA molecules that play a role in regulating gene expression.

Chromosome 11 is known to contain several important genes and genetic regions associated with various human diseases and conditions. For example, it contains the Wilms' tumor 1 (WT1) gene, which is associated with kidney cancer in children, and the neurofibromatosis type 1 (NF1) gene, which is associated with a genetic disorder that causes benign tumors to grow on nerves throughout the body. Additionally, chromosome 11 contains the region where the ABO blood group genes are located, which determine a person's blood type.

It's worth noting that human chromosomes come in pairs because they contain two copies of each gene, one inherited from the mother and one from the father. This redundancy allows for genetic diversity and provides a backup copy of essential genes, ensuring their proper function and maintaining the stability of the genome.

Retinal vessels refer to the blood vessels that are located in the retina, which is the light-sensitive tissue that lines the inner surface of the eye. The retina contains two types of blood vessels: arteries and veins.

The central retinal artery supplies oxygenated blood to the inner layers of the retina, while the central retinal vein drains deoxygenated blood from the retina. These vessels can be visualized during a routine eye examination using an ophthalmoscope, which allows healthcare professionals to assess their health and any potential abnormalities.

Retinal vessels are essential for maintaining the health and function of the retina, and any damage or changes to these vessels can affect vision and lead to various eye conditions such as diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy.

An injection is a medical procedure in which a medication, vaccine, or other substance is introduced into the body using a needle and syringe. The substance can be delivered into various parts of the body, including into a vein (intravenous), muscle (intramuscular), under the skin (subcutaneous), or into the spinal canal (intrathecal or spinal).

Injections are commonly used to administer medications that cannot be taken orally, have poor oral bioavailability, need to reach the site of action quickly, or require direct delivery to a specific organ or tissue. They can also be used for diagnostic purposes, such as drawing blood samples (venipuncture) or injecting contrast agents for imaging studies.

Proper technique and sterile conditions are essential when administering injections to prevent infection, pain, and other complications. The choice of injection site depends on the type and volume of the substance being administered, as well as the patient's age, health status, and personal preferences.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

The conjunctiva is the mucous membrane that lines the inner surface of the eyelids and covers the front part of the eye, also known as the sclera. It helps to keep the eye moist and protected from irritants. The conjunctiva can become inflamed or infected, leading to conditions such as conjunctivitis (pink eye).

Fibronectin is a high molecular weight glycoprotein that is found in many tissues and body fluids, including plasma, connective tissue, and the extracellular matrix. It is composed of two similar subunits that are held together by disulfide bonds. Fibronectin plays an important role in cell adhesion, migration, and differentiation by binding to various cell surface receptors, such as integrins, and other extracellular matrix components, such as collagen and heparan sulfate proteoglycans.

Fibronectin has several isoforms that are produced by alternative splicing of a single gene transcript. These isoforms differ in their biological activities and can be found in different tissues and developmental stages. Fibronectin is involved in various physiological processes, such as wound healing, tissue repair, and embryonic development, and has been implicated in several pathological conditions, including fibrosis, tumor metastasis, and thrombosis.

Triamcinolone Acetonide is a synthetic glucocorticoid, which is a class of corticosteroids. It is used in the form of topical creams, ointments, and sprays to reduce skin inflammation, itching, and allergies. It can also be administered through injection for the treatment of various conditions such as arthritis, bursitis, and tendonitis. Triamcinolone Acetonide works by suppressing the immune system's response, reducing inflammation, and blocking the production of substances that cause allergies.

It is important to note that prolonged use or overuse of triamcinolone acetonide can lead to side effects such as thinning of the skin, easy bruising, and increased susceptibility to infections. Therefore, it should be used under the guidance of a healthcare professional.

Laser coagulation, also known as laser photocoagulation, is a medical procedure that uses a laser to seal or destroy abnormal blood vessels or tissue. The laser produces a concentrated beam of light that can be precisely focused on the target area. When the laser energy is absorbed by the tissue, it causes the temperature to rise, which leads to coagulation (the formation of a clot) or destruction of the tissue.

In ophthalmology, laser coagulation is commonly used to treat conditions such as diabetic retinopathy, age-related macular degeneration, and retinal tears or holes. The procedure can help to seal leaking blood vessels, reduce fluid leakage, and prevent further vision loss. It is usually performed as an outpatient procedure and may be repeated if necessary.

In other medical specialties, laser coagulation may be used to control bleeding, destroy tumors, or remove unwanted tissue. The specific technique and parameters of the laser treatment will depend on the individual patient's needs and the condition being treated.

Fibroblasts are specialized cells that play a critical role in the body's immune response and wound healing process. They are responsible for producing and maintaining the extracellular matrix (ECM), which is the non-cellular component present within all tissues and organs, providing structural support and biochemical signals for surrounding cells.

Fibroblasts produce various ECM proteins such as collagens, elastin, fibronectin, and laminins, forming a complex network of fibers that give tissues their strength and flexibility. They also help in the regulation of tissue homeostasis by controlling the turnover of ECM components through the process of remodeling.

In response to injury or infection, fibroblasts become activated and start to proliferate rapidly, migrating towards the site of damage. Here, they participate in the inflammatory response, releasing cytokines and chemokines that attract immune cells to the area. Additionally, they deposit new ECM components to help repair the damaged tissue and restore its functionality.

Dysregulation of fibroblast activity has been implicated in several pathological conditions, including fibrosis (excessive scarring), cancer (where they can contribute to tumor growth and progression), and autoimmune diseases (such as rheumatoid arthritis).

Platelet-Derived Growth Factor (PDGF) is a dimeric protein with potent mitogenic and chemotactic properties that plays an essential role in wound healing, blood vessel growth, and cellular proliferation and differentiation. It is released from platelets during the process of blood clotting and binds to specific receptors on the surface of target cells, including fibroblasts, smooth muscle cells, and glial cells. PDGF exists in several isoforms, which are generated by alternative splicing of a single gene, and have been implicated in various physiological and pathological processes, such as tissue repair, atherosclerosis, and tumor growth.

Fluorescein angiography is a medical diagnostic procedure used in ophthalmology to examine the blood flow in the retina and choroid, which are the inner layers of the eye. This test involves injecting a fluorescent dye, Fluorescein, into a patient's arm vein. As the dye reaches the blood vessels in the eye, a specialized camera takes rapid sequences of photographs to capture the dye's circulation through the retina and choroid.

The images produced by fluorescein angiography can help doctors identify any damage to the blood vessels, leakage, or abnormal growth of new blood vessels. This information is crucial in diagnosing and managing various eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, and inflammatory eye diseases.

It's important to note that while fluorescein angiography is a valuable diagnostic tool, it does carry some risks, including temporary side effects like nausea, vomiting, or allergic reactions to the dye. In rare cases, severe adverse reactions can occur, so patients should discuss these potential risks with their healthcare provider before undergoing the procedure.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

The name Proliferative vitreo retinopathy was provided in 1989 by the Silicone Oil Study group. The name is derived from ... Proliferative vitreoretinopathy (PVR) is a disease that develops as a complication of rhegmatogenous retinal detachment. PVR ... "Proliferative Vitreoretinopathy". Retina and Vitreous of Texas. Archived from the original on 2004-05-06. Retrieved 2009-05-28 ... Leaver PK (1995). "Proliferative vitreoretinopathy". British Journal of Ophthalmology. 79 (10): 871-872. doi:10.1136/bjo.79.10. ...
Sadaka A, Giuliari GP (January 2012). "Proliferative vitreoretinopathy: current and emerging treatments". Clinical ... Proliferative vitreoretinopathy has been observed in cases of retinal detachment. The diagnosis of CMV retinitis can be done ...
Cantó Soler MV, Gallo JE, Dodds RA, Suburo AM (November 2002). "A mouse model of proliferative vitreoretinopathy induced by ... Dispase intravitreal injection can be used in the modeling of proliferative vitreoretinopathy in different animals. Weimer; et ... "THE CHARACTERISTICS OF RETINA AT THE DEVELOPMENT OF PROLIFERATIVE VITREORETINOPATHY IN RATS AFTER INTRAOCULAR INJECTION OF ... "Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a ...
"Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy". The Cochrane Database of ...
1990). "Immunocytochemical study of an eye with proliferative vitreoretinopathy and retinal tacks". Retina. 10 (1): 78-85. doi: ...
Eye inflammation, medications including anti glaucoma drugs, or proliferative vitreoretinopathy causes decreased production. ...
ConA intravitreal injection can be used in the modeling of proliferative vitreoretinopathy in rats. PDB: 3CNA​; Hardman KD, ... The characteristics of retina at the development of proliferative vitreoretinopathy in rats after intraocular injection of ... "Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a ...
"Dedifferentiation of the retinal pigment epithelium compared to the proliferative membranes of proliferative vitreoretinopathy ...
Silicone oil is more commonly used in cases associated with proliferative vitreo-retinopathy (PVR). Silicone oil may be light ... Tractional retinal detachments can also occur in patients with proliferative diabetic retinopathy or those with proliferative ... In proliferative retinopathy, abnormal blood vessels (neovascularization) grow within the retina and extend into the vitreous. ... and where there is proliferative vitreous retinopathy.[citation needed] Pneumatic retinopexy This operation is generally ...
He established an animal model of retinal detachment and used this model to study proliferative vitreoretinopathy (PVR), which ... Aaberg TM (2010). "Surgery as the primary management of proliferative vitreoretinopathy: a history reflecting my experiences ...
"Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a ...
"Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina". Glia. 39 (3): ...
... or proliferative vitreoretinopathy causes decreased production. Increased outflow or aqueous loss may occur following a ...
His clinical papers focus on proliferative vitreoretinopathy (PVR), age-related macular degeneration (AMD), central retinal ... diabetic retinopathy and proliferative vitreoretinopathy (PVR). He was a member of the directorate of the University Hospital ...
His basic science research focused on the pathophysiology and cellular events related to vitreoretinopathy. He participated in ... retinopathy of prematurity and other proliferative retinal diseases, and the development of new surgical techniques. ...
... first identified in 1990 Familial exudative vitreoretinopathy, a genetic eye disorder Proliferative vitreoretinopathy, a ... Vitreoretinopathy may refer to: Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV), a rare inherited ... to rhegmatogenous retinal detachment This disambiguation page lists articles associated with the title Vitreoretinopathy. If an ...
... such as those complicated with proliferative vitreoretinopathy, large retinal tears, and penetrating ocular trauma. ...
This has therapeutic implications on the treatment of proliferative vitreoretinopathy, as this condition can lead to retinal ...
... has been used intravitreally (inside the eye) for the purposes of preventing proliferative vitreoretinopathy, a ...
... vitreoretinopathy, proliferative MeSH C11.790.500 - scleritis MeSH C11.941.160 - choroid diseases MeSH C11.941.160.177 - ...
LRP5 Exudative vitreoretinopathy 5; 613310; TSPAN12 Exudative vitreoretinopathy; 133780; FZD4 Exudative vitreoretinopathy, X- ... PEPD Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome; 225790; FLVCR2 Properdin deficiency, X-linked; 312060 ...
The name Proliferative vitreo retinopathy was provided in 1989 by the Silicone Oil Study group. The name is derived from ... Proliferative vitreoretinopathy (PVR) is a disease that develops as a complication of rhegmatogenous retinal detachment. PVR ... "Proliferative Vitreoretinopathy". Retina and Vitreous of Texas. Archived from the original on 2004-05-06. Retrieved 2009-05-28 ... Leaver PK (1995). "Proliferative vitreoretinopathy". British Journal of Ophthalmology. 79 (10): 871-872. doi:10.1136/bjo.79.10. ...
Proliferative vitreoretinopathy (PVR) is a serious complication of retinal detachment and ocular trauma and its recurrence may ... Proliferative vitreoretinopathy (PVR) is a serious complication of retinal detachment and ocular trauma and its recurrence may ... Proliferative vitreoretinopathy (PVR) can occur in eyes after rhegmatogenous retinal detachment or after major ocular trauma ... Tosi, G. M., Marigliani, D., Romeo, N. & Toti, P. Disease pathways in proliferative vitreoretinopathy: an ongoing challenge. J ...
... the retinal pigment epithelial cells may have some relationship to the anatomical results for proliferative vitreoretinopathy ... Dedifferentiation of the retinal pigment epithelium compared to the proliferative membranes of proliferative vitreoretinopathy ... Of the anatomically unsuccessful patients with proliferative vitreoretinopathy treated by surgery, 76.9% showed both tyrosinase ... and cultured retinal pigment epithelial cells and in proliferative membranes in patients with proliferative vitreoretinopathy. ...
Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review. Dai Y, Dai C, Sun T. Dai Y, et al. Int ... SINGLE NUCLEOTIDE POLYMORPHISMS IN RETINAL DETACHMENT PATIENTS WITH AND WITHOUT PROLIFERATIVE VITREORETINOPATHY Xhevat Lumi 1 ... Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 2016;51: ... SINGLE NUCLEOTIDE POLYMORPHISMS IN RETINAL DETACHMENT PATIENTS WITH AND WITHOUT PROLIFERATIVE VITREORETINOPATHY Xhevat Lumi et ...
Late versus prophylactic chorioretinectomy for the prevention of trauma-related proliferative vitreoretinopathy.. Ferenc Kuhn, ... have a high risk for developing either full-blown proliferative vitreoretinopathy (PVR) or full-thickness retinal folds. ...
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology. 2001 Jul. 108(7):1184-6. [QxMD MEDLINE Link ... Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol. 1983 Jul. 96(1):33-42. [QxMD ... Adjunctive therapies for proliferative vitreoretinopathy. Int Ophthalmol Clin. 2004. 44(3):1-10. [QxMD MEDLINE Link]. ... A new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol. 1984 Aug. 102(8):1220-3. [QxMD MEDLINE Link]. ...
Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy *B N M K Khanum. *R Guha ...
From anti-VEGF agents to emerging therapies for proliferative vitreoretinopathy, some of the best presentations in retina from ... Emerging Therapies for Proliferative Vitreoretinopathy Switching gears, Dr Richard Kaiser[6] presented an overview of current ... and emerging therapies for the bane of surgical retinal detachment repair: proliferative vitreoretinopathy (PVR). ...
Proliferative Vitreoretinopathy Market: What are the Key Growth Factors?. Mahendra Singh - June 3, 2021. ...
Cytokines in proliferative vitreoretinopathy.. Posted at 19:41h in Ophthalmology Library by admin 0 Comments Share. ... Cytokines in proliferative vitreoretinopathy.. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell ... from eyes undergoing vitrectomy for the treatment of retinal detachment complicated by proliferative vitreoretinopathy (PVR) or ...
Machemer R Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Invest Ophthalmol Vis ... Machemer R Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Invest Ophthalmol Vis ... Jaffe GJPearson PA Proliferative vitreoretinopathy: biology and pharmacology. Weinberg DVJampol LMeds. Ophthalmic Pharmacology. ... Jaffe GJPearson PA Proliferative vitreoretinopathy: biology and pharmacology. Weinberg DVJampol LMeds. Ophthalmic Pharmacology. ...
Surgery For Proliferative Vitreoretinopathy. Proliferative vitreoretinopathy (PVR) is the most common complication following a ...
Proliferative Vitreo-retinopathy - Grade B - Pigment in Vitreous. 72 year old woman. Had subconjunctival hemorrhage and checked ... Grade B Proliferative Vitreo-retinopathy - Pigment in Anterior Vitreous - Chronic Retinal Detachment564 views72 year old woman ... Grade B Proliferative Vitreo-retinopathy - Pigment in Anterior Vitreous - Chronic Retinal Detachment495 views72 year old woman ... Grade B Proliferative Vitreo-retinopathy - Pigment in Anterior Vitreous - Chronic Retinal Detachment741 views72 year old woman ...
Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study. Abdussalam M Abdullatif ... Dive into the research topics of Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a ...
... proliferative vitreoretinopathy (PVR), giant retinal tear (GRT), or retinopathy of prematurity (ROP). ...
Shorter axial length is a risk factor for proliferative vitreoretinopathy grade C in eyes unmodified by surgical invasion. In: ... Shorter axial length is a risk factor for proliferative vitreoretinopathy grade C in eyes unmodified by surgical invasion. ... Shorter axial length is a risk factor for proliferative vitreoretinopathy grade C in eyes unmodified by surgical invasion」の研究 ... Shorter axial length is a risk factor for proliferative vitreoretinopathy grade C in eyes unmodified by surgical invasion. / ...
Proliferative Vitreoretinopathy (Orphan). Orphan designation for prevention of proliferative vitreoretinopathy (PVR). Orphan ...
Retrospective, noncomparative study of patients with retinal detachment and posterior proliferative vitreoretinopathy followed ... evaluate anatomical and functional outcomes after silicone oil extraction in patients with retinal detachment and proliferative ... vitreoretinopathy in an eye care referral center in Joinville, SC, southern Brazil. ... Inicial operative procedure: rhegmatogenous retinal detachment and grade C posterior proliferative vitreoretinopathy (A) and ...
Intraoperative OCT-Assisted Surgical Management of Proliferative Vitreoretinopathy Proliferative vitreoretinopathy (PVR) is a ...
Translational and clinical advancements in management of proliferative vitreoretinopathy.; Current opinion in ophthalmology. ... Severe Familial Exudative Vitreoretinopathy, Congenital Hearing Loss, and Developmental Delay in a Child With Biallelic ... MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents.; ... smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.; PloS ...
... and grade C proliferative vitreoretinopathy (PVR)). Additional characteristics of patients were then elucidated including ...
Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice. Previous Article in Special Issue ...
Proliferative Vitreoretinopathy Detachments Giant Retinal Tear Detachments Chapter 4 Peeling 101 Viewing Systems Stains When ...
Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis ... Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis ... Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. . Invest Ophthalmol ... Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. . Invest Ophthalmol ...
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.. Abu El-Asrar AM; Struyf S; Kangave D; ... C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. ...
TAGS: caveolins, epithelial to mesenchymal transition, vitreoretinopathy, proliferative, mice Invest. Ophthalmol. Vis. Sci.. ... Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy PDF ...
Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye 2002;16:369-74.doi:10.1038/sj. ... Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev 2020;5: ... grade C proliferative vitreoretinopathy (PVR).3-5 RRD associated with inferior retinal breaks located at a position between 4 ... Non-buckled vitrectomy for retinal detachment with inferior breaks and proliferative vitreoretinophathy. Int J Ophthalmol 2012; ...
... ophthalmic conditions associated with cell proliferation such as proliferative vitreoretinopathy; cutaneous diseases such as ...
  • Coral K, Angayarkanni N, Gomathy N, Bharathselvi M, Pukhraj R, Rupak R. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase. (medscape.com)
  • Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. (medscape.com)
  • Silicone oil (SO) is used mainly when managing complex retinal detachments, commonly with proliferative vitreoretinopathy, and as a hemostatic agent in proliferative diabetic retinopathy [1] . (researchsquare.com)
  • An advantage of sequential surgery is that it induces less postoperative anterior chamber inflammation, and thus may be recommended in proliferative diabetic retinopathy or retinal detachment [2,3] . (researchsquare.com)
  • This condition is most commonly associated with proliferative diabetic retinopathy, sickle cell disease, advanced retinopathy of prematurity. (institut-vision.org)
  • Combined retinal detachments with features of ERD and TRD may be associated with proliferative diabetic retinopathy or proliferative vitreoretinopathy and trauma. (institut-vision.org)
  • A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy. (ox.ac.uk)
  • The development of proliferative vitreoretinopathy with retinal detachment in 4 patients was the main complication observed after pars plana vitrectomy. (thieme-connect.de)
  • Fundus color montage of a case with bilateral Familial Exudative Vitreoretinopathy: retinal vessel dragging from optic disc toward temporal retina, peripheral avascular zone, inferior proliferative vitreoretinal traction. (zeiss.com)
  • Complicated retinal detachments with severe posterior and anterior proliferative vitreoretinopathy (PVR) were included in this study. (springer.com)
  • Seventy-six consecutive patients with total rhegmatogenous retinal detachments and severe proliferative vitreoretinopathy underwent combined pars plana vitrectomy, lensectomy, panretinal photocoagulation, perfluoropropane gas (C3F8)/fluid exchange, and scleral buckling. (nih.gov)
  • Abrams GW, Azen SP, McCuen BW II, Flynn HW Jr, Lai MY, Ryan SJ (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. (springer.com)
  • If several operations are required to repair proliferative vitreoretinopathy, poor vision may result even with a successfully attached retina. (medscape.com)
  • Figure 10-9 Preretinal membrane (area between arrows) on the surface of the retina, secondary to proliferative vitreoretinopathy. (aao.org)
  • Localized scatter photocoagulation is effective in treating early proliferative changes, especially neovascular lesions that lie flat against the retina. (medscape.com)
  • Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy. (medscape.com)
  • 2. Charteris DG, Downie J, Aylward GW, Sethi C, Luthert P. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. (medline.ru)
  • Anterior proliferative vitreoretinopathy in the silicone study. (medline.ru)
  • 11. Hocaoglu M, Karacorlu M, Giray Ersoz M, Sayman Muslubas I, Arf S. Retinotomy and retinectomy for anterior inferior proliferative vitreoretinopathy: Can visual outcome be improved? (medline.ru)
  • This can occur in such cases as hypotony due to anterior proliferative vitreoretinopathy (PVR), persistent cystoid macular edema (CME) after complicated cataract surgery with retained lens fragments, and endophthalmitis. (ophthalmologytimes.com)
  • Our pre-commercial product candidates are reproxalap, a potential treatment for dry eye disease and allergic conjunctivitis, and ADX-2191, a potential treatment for primary vitreoretinal lymphoma, proliferative vitreoretinopathy, and retinitis pigmentosa. (businesswire.com)
  • The Company is currently developing ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma cancer, proliferative vitreoretinopathy, and retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. (woodtv.com)
  • Proliferative vitreoretinopathy (PVR) is a disease that develops as a complication of rhegmatogenous retinal detachment. (wikipedia.org)
  • Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment (RD). Proliferative vitreoretinopathy (PVR) is primarily a result of failure to correct RRD after initial retinal reattachment surgery, occurs in 5%-10% of patients, and may lead to recurrent RD. 1 Further surgery is the only proven therapy for recurrent RD with PVR. (dovepress.com)
  • Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. (medline.ru)
  • Comparison of Peroperative Methotrexate Infusion With Postoperative Intra Silicon Oil Methotrexate Injections for Prevention of Proliferative Vitreoretinopathy Development After Vitrectomy for Rhegmatogenous Retinal Detachment Repair. (who.int)
  • Since vitreous hemorrhage and retinal detachment account for most visual loss in hemoglobinopathies, the primary goal in treating proliferative sickle retinopathy is to minimize or eliminate neovascularization. (medscape.com)
  • Different techniques have been advocated in treating proliferative sickle retinopathy, including scatter photocoagulation and feeder vessel photocoagulation. (medscape.com)
  • This technique has been shown to manage proliferative sickle retinopathy effectively, especially in cases where neovascularization has persisted after extensive scatter photocoagulation treatment. (medscape.com)
  • and NF-?B signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. (rochester.edu)
  • Garweg JG, Tappeiner C, Halberstadt M. Pathophysiology of proliferative vitreoretinopathy in retinal detachment. (aao.org)
  • Proliferative vitreoretinopathy can occur from glial or retinal pigment epithelium (RPE) proliferation. (medscape.com)
  • Tolerability and Efficacy of Multiple Series of Intravitreal Methotrexate Injections for Complex Retinal Detachment Associated with Proliferative Vitreoretinopathy. (ucsf.edu)
  • Mysore Y, Del Amo EM, Loukovaara S, Hagström M, Urtti A, Kauppinen A. Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous . (helsinki.fi)
  • The name Proliferative vitreo retinopathy was provided in 1989 by the Silicone Oil Study group. (wikipedia.org)
  • Cox MS, Trese MT, Murphy PL (1986) Silicone oil for advanced proliferative vitreoretinopathy. (springer.com)
  • Epimacular membranes occurring after retinal detachment surgery can be thought of as limited proliferative vitreoretinopathy. (medscape.com)
  • Proliferative vitreoretinopathy (PVR) is a disease that causes severe blindness and is characterized by the formation of contractile fibrotic subretinal or epiretinal membranes. (stanford.edu)
  • Specific platelet-derived growth element (PDGF) isoforms are connected with proliferative vitreoretinopathy (PVR), a sight-threatening complication that develops inside a subset of individuals dealing with retinal reattachment surgery. (woofahs.com)
  • Proliferative vitreoretinopathy (PVR) is the most common cause of failure in retinal detachment surgery. (medscape.com)
  • Of all retinal detachment surgery cases, 5-10% develop proliferative vitreoretinopathy. (medscape.com)
  • PURPOSE: Proliferative vitreoretinopathy (PVR) is still the major cause of failure of retinal detachment (RD) surgery and although the risk for developing this complication is associated with some clinical characteristics, the correlation is far from absolute, raising the possibility of genetic susceptibility. (ox.ac.uk)
  • Presence of proliferative vitreoretinopathy grade C, previous retinal detachment surgery in the same eye, penetrating ocular trauma, Presence of intraocular foreign bodies, previous glaucoma filtration surgery, allergy to methotrexate, and pregnant and lactating women. (who.int)
  • However, in cases where scatter photocoagulation alone does not achieve the desired result (ie, regression of proliferative changes), feeder vessel photocoagulation may be used as an adjunct to induce infarction to the remaining sea fans. (medscape.com)
  • To determine differences of K + channel activity between Müller glial cells obtained from retinas of healthy human donors and of patients with retinal detachment and proliferative vitreoretinopathy. (arvojournals.org)
  • RRD patients with or without proliferative vitreoretinopathy (PVR) were included. (dovepress.com)
  • Although proliferative vitreoretinopathy can occur at all ages, some observers believe that proliferative tissue may develop more rapidly in children. (medscape.com)
  • Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy. (medscape.com)
  • Translational and clinical advancements in management of proliferative vitreoretinopathy. (rochester.edu)
  • however, recurrence rates for retinal detachment could be as high as 10% to 20%, 1 and even higher in the presence of proliferative vitreoretinopathy (PVR). (bmj.com)
  • To evaluate the effect of extrascleral cryocoagulation for the treatment of proliferative vitreoretinopathy (PVR) during retinal detachment repair. (kssg.ch)
  • 4. Pastor JC, de la Rúa ER, Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. (medline.ru)
  • The increased activity of BK channels may support the proliferative activity of gliotic cells via feedback regulation of Ca 2+ entry and membrane potential. (arvojournals.org)
  • Penetrating or blunt trauma may also result in proliferative vitreoretinopathy. (medscape.com)
  • Intro Proliferative vitreoretinopathy (PVR) can be a blinding disease occurring in up to 10% of individuals dealing with retinal reattachment medical procedures (16, 23, 52). (woofahs.com)
  • Proliferative vitreoretinopathy (PVR) is a blind-causing disease initiated by the activation of retinal pigmented epithelium (RPE) primarily induced by TGF-β families. (stanford.edu)
  • Proton magnetic resonance imaging (MRI) was employed to obtain information on early vitreal changes preceding ophthalmoscopically visible proliferative vitreoretinopathy. (unimib.it)
  • Proliferative vitreoretinopathy is a reparative process, similar to a keloid, initiated by full- or partial-thickness retinal breaks, retinopexy, and other types of retinal damage. (medscape.com)
  • en-INT_31_173_0139I This is a code assigned to all external communications materials, to assist in tracking and monitoring during the internal approval process. (zeiss.com)
  • Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. (medscape.com)
  • University Medical tive retinal detachment, and proliferative vitreoretinopathy. (cdc.gov)

No images available that match "vitreoretinopathy proliferative"